A Single-Arm Study to Evaluate Administration of Lebrikizumab by Participants or Caregivers in the Home Setting

NCT02546869 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped The study was withdrawn due to an internal decision.

Conditions

Asthma

Interventions

DRUG: Lebrikizumab
DEVICE: Prefilled Syringes

Sponsor

Hoffmann-La Roche